Free Trial

Landscape Capital Management L.L.C. Has $592,000 Stake in The Chemours Company (NYSE:CC)

Chemours logo with Basic Materials background
Remove Ads

Landscape Capital Management L.L.C. lifted its holdings in The Chemours Company (NYSE:CC - Free Report) by 243.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 35,032 shares of the specialty chemicals company's stock after purchasing an additional 24,837 shares during the period. Landscape Capital Management L.L.C.'s holdings in Chemours were worth $592,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. Strategic Financial Concepts LLC acquired a new position in shares of Chemours during the fourth quarter worth approximately $357,000. Two Sigma Advisers LP boosted its holdings in Chemours by 9.4% in the 3rd quarter. Two Sigma Advisers LP now owns 503,100 shares of the specialty chemicals company's stock valued at $10,223,000 after purchasing an additional 43,200 shares during the period. Entropy Technologies LP acquired a new stake in Chemours in the 4th quarter worth $266,000. Twelve Points Wealth Management LLC raised its position in shares of Chemours by 42.8% during the fourth quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company's stock valued at $1,324,000 after buying an additional 23,490 shares during the last quarter. Finally, Sei Investments Co. lifted its stake in shares of Chemours by 779.5% in the fourth quarter. Sei Investments Co. now owns 174,555 shares of the specialty chemicals company's stock valued at $2,950,000 after buying an additional 154,709 shares during the period. Institutional investors and hedge funds own 76.26% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CC. Mizuho upgraded Chemours from a "neutral" rating to an "outperform" rating and set a $19.00 price target on the stock in a research note on Thursday, March 27th. Royal Bank of Canada restated an "outperform" rating and issued a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. The Goldman Sachs Group decreased their price target on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a research note on Tuesday, January 7th. Truist Financial assumed coverage on shares of Chemours in a research note on Tuesday, January 28th. They issued a "buy" rating and a $27.00 price objective for the company. Finally, BMO Capital Markets cut their price target on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $22.56.

Remove Ads

View Our Latest Analysis on Chemours

Chemours Price Performance

NYSE CC traded down $0.17 during trading hours on Friday, reaching $10.64. 523,638 shares of the company's stock were exchanged, compared to its average volume of 1,806,785. The firm has a fifty day moving average of $14.69 and a 200-day moving average of $17.67. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The Chemours Company has a one year low of $9.33 and a one year high of $29.21. The stock has a market cap of $1.59 billion, a PE ratio of 18.67 and a beta of 1.84.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. On average, equities research analysts predict that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 9.40%. Chemours's dividend payout ratio (DPR) is currently 175.44%.

About Chemours

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Read More

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Should You Invest $1,000 in Chemours Right Now?

Before you consider Chemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.

While Chemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

These Are the 3 Stocks Most Likely to SPLIT in 2025

These Are the 3 Stocks Most Likely to SPLIT in 2025

MarketBeat analyst Thomas Hughes breaks down why companies split their stock and reveals his top three picks most likely to split next year.

Related Videos

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
5 Stocks to BUY NOW in February 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads